Jeevan Biosciences, Inc. is a biotechnology company that is focused on identifying novel biomarkers for the commercialization of research, diagnostic, and therapeutic products. The company includes the development of stem cell products and intellectual property to be used for the diagnosis, treatment, and overall improvement of patient care. Jeevan Biosciences' areas of interest include Fetal Alcohol Spectrum Disorder (FASD), Gliomblastoma, and HIV/NeuroAIDS.
